Document is current
Any future updates will be listed below
-
Authors
Oliver, N T
Nieto, Y L
Blechacz, B
Anderlini, P
Ariza-Heredia, E
Torres, H A
- License Information
-
More Information
Article History
First Online: 18 July 2016
Competing interests
: HAT is or has been the principal investigator for research grants from Gilead Sciences, Merck & Co., Inc., and Vertex Pharmaceuticals, with all funds paid to The University of Texas MD Anderson Cancer Center. HAT is or has been a paid scientific advisor for Gilead Sciences, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Vertex Pharmaceuticals, Genentech, Novartis, Astellas Pharma, Pfizer Inc., and Theravance Biopharma, Inc.; the terms of these arrangements are being managed by MD Anderson Cancer Center in accordance with its conflict-of-interest policies.
